Nurse Anesthetist - CR in Denison, IA Accepting Medicare

4 Nurse Anesthetist - CR nurses found. Showing 1 - 4

Mr. Charles Reginald Elam Iv, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Pkwy, Denison, IA 51442 Phone: 712-265-2683    Fax: 712-265-2682

Paul G. Gartner, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2020 1st Ave S, Denison, IA 51442 Phone: 712-263-5021    Fax: 712-263-1600

Julie Dekker Flint, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Pkwy, Denison, IA 51442 Phone: 712-265-2500

Mr. Robert J. Ballard, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2020 1st Ave S, Denison, IA 51442 Phone: 712-263-5021    Fax: 712-263-1600

News Archive

Study reveals how B cells react to SARS-CoV-2

In an exciting immunological medRxiv preprint paper, researchers from Germany and Russia analyzed adaptive immune response in severely affected patients with coronavirus disease (COVID-19). They demonstrated a protracted immune reaction characterized by egress of B lymphocytes into the blood.

Study confirms safety of two measles-containing vaccines

A 12-year study of two measles-containing vaccines, published today in Pediatrics, found that seven main adverse outcomes were unlikely after either vaccine.

Seriously mentally ill are three times more likely to be imprisoned than hospitalized, report finds

USA Today: "On average, a seriously mentally ill person in the USA is three times more likely to be incarcerated than hospitalized, a report concludes today. In no state was a seriously mentally ill person — someone with schizophrenia or bipolar disorder, for example — less likely to be incarcerated than hospitalized, the report by the National Sheriffs' Association and the Treatment Advocacy Center found.

pSivida reports that Alimera Sciences gets FDA Complete Response Letter for ILUVIEN NDA

pSivida Corp., a specialty pharmaceutical company that is a leader in developing sustained release drugs for treatment of back-of-the-eye diseases, today announced that its licensee Alimera Sciences, Inc. has received a Complete Response Letter for the New Drug Application for ILUVIEN from the U.S. Food and Drug Administration.

Read more Medical News

› Verified 2 days ago